Connecticut HB 5225: AN ACT PROHIBITING CERTAIN LICENSEES AND REGISTRANTS FROM SELLING, DISPENSING, TRANSFERRING OR DELIVERING ANY DRUG OR DEVICE TO EXECUTE A COURT-IMPOSED SENTENCE OF DEATH.

Bill Text

LCO  
 
1 of 20 
  
General Assembly  
Substitute Bill No. 5225  
February Session, 2026 
 
 
 
 
 
AN ACT PROHIBITING CERTAIN LICENSEES AND REGISTRANTS 
FROM SELLING, DISPENSING, TRANSFERRING OR DELIVERING 
ANY DRUG OR DEVICE TO EXECUTE A COURT-IMPOSED 
SENTENCE OF DEATH.  
Be  it  enacted  by  the  Senate  and  House  of  Representatives  in  General 
Assembly convened: 
 
Section  1.  Section  21a-70 of  the  2026  supplement  to  the  general 1 
statutes  is  repealed  and  the  following  is  substituted  in  lieu  thereof 2 
(Effective October 1, 2026): 3 
(a) As  used  in  this  section: [(1)  "Drugs",  "devices"  and  "cosmetics" 4 
have  the  same  meanings  as  defined  in  section  21a-92,  "wholesaler"  or 5 
"distributor"  means  a  person,  including,  but  not  limited  to,  a  medical 6 
device  and  oxygen  provider,  a  third-party  logistics  provider,  a  virtual 7 
manufacturer  or  a  virtual  wholesale  distributor,  as  such  terms  are 8 
defined in section 20-571, whether within or without the boundaries of 9 
the  state  of  Connecticut,  who  supplies  drugs,  devices  or  cosmetics 10 
prepared,    produced    or    packaged    by    manufacturers,    to    other 11 
wholesalers,     manufacturers,     distributors,     hospitals,     prescribing 12 
practitioners, as defined in section 20-571, pharmacies, federal, state or 13 
municipal  agencies,  clinics  or  any  other  person  as  permitted  under 14 
subsection  (h)  of  this  section,  except  that:  (A)  A  retail  pharmacy  or  a 15 
pharmacy  within  a  licensed  hospital  that  supplies  to  another  such 16 
pharmacy a quantity of a noncontrolled drug or a schedule II, III, IV or 17 

Substitute Bill No. 5225 
 
 
LCO      2 of 20 
 
V controlled substance normally stocked by such pharmacies to provide 18 
for  the  immediate  needs  of  a  patient  pursuant  to  a  prescription  or 19 
medication order of an authorized practitioner, (B) a pharmacy within a 20 
licensed   hospital   that   supplies   drugs   to   another   hospital   or   an 21 
authorized practitioner for research purposes, (C) a retail pharmacy that 22 
supplies a limited quantity of a noncontrolled drug or of a schedule II, 23 
III,  IV  or  V  controlled  substance  for  emergency  stock  to  a  practitioner 24 
who is a medical director of a chronic and convalescent nursing home, 25 
of a rest home with nursing supervision, of a hospice inpatient facility 26 
licensed pursuant to section 19a-491 or of a state correctional institution, 27 
and  (D)  a  pharmacy  within  a  licensed  hospital  that  contains  another 28 
hospital  wholly  within such  licensed  hospital's physical  structure  that 29 
supplies to such contained hospital a quantity of a noncontrolled drug 30 
or a schedule II, III, IV, or V controlled substance normally stocked by 31 
such  hospitals  to  provide  for  the  needs  of  a  patient,  pursuant  to  a 32 
prescription or medication order of an authorized practitioner, receiving 33 
inpatient  care  on  a  unit  that  is  operated  by  the  contained  hospital,  or 34 
receiving outpatient care in a setting operated by the contained hospital 35 
and  such  drug  or  substance  is  administered  on-site  by  the  contained 36 
hospital,  shall  not  be  deemed  a  wholesaler  under  this  section;  (2) 37 
"manufacturer"  means  (A)  a  person,  whether  within  or  without  the 38 
boundaries   of   the   state   of   Connecticut,   who   produces,   prepares, 39 
cultivates,   grows,   propagates,   compounds,   converts   or   processes, 40 
directly or indirectly, by extraction from substances of natural origin or 41 
by means of chemical  synthesis or by a combination of extraction and 42 
chemical  synthesis,  or  who  packages,  repackages,  labels  or  relabels  a 43 
container  under  such  manufacturer's  own  or  any  other  trademark  or 44 
label any drug, device or cosmetic for the purpose of selling such items, 45 
or (B) a sterile compounding pharmacy, as  defined in section 20-633b, 46 
that  dispenses  sterile  pharmaceuticals  without  a  prescription  or  a 47 
patient-specific medical order; (3) "drug", "device" and "cosmetic" have 48 
the    same    meanings    as    provided    in    section    21a-92;    and    (4) 49 
"commissioner"  means  the  Commissioner  of  Consumer  Protection  or 50 
the commissioner's designee.] 51 

Substitute Bill No. 5225 
 
 
LCO      3 of 20 
 
(1)    "Commissioner"    means    the    Commissioner    of    Consumer 52 
Protection; 53 
(2) "Cosmetic" has the same meaning as provided in section 21a-92; 54 
(3) "Device" has the same meaning as provided in section 21a-92; 55 
(4) "Distributor" or "wholesaler" (A) means a person, including,  but 56 
not  limited  to,  a  medical  device  and  oxygen  provider,  a  third-party 57 
logistics   provider,   a   virtual   manufacturer   or   a   virtual   wholesale 58 
distributor, as such terms are defined in section 20-571,